Nathan Seppa has been the biomedical writer at Science News since 1997. Previously, he worked at the Wisconsin State Journal, a daily newspaper in Madison, where he inaugurated the science beat. In the 1980s, he covered energy and economics for the Dow Jones News Service in the Wall Street Journal's Washington Bureau. In the 1970s, Seppa served as a public health volunteer in the Peace Corps in Zaire, now Congo. He hails from the Upper Peninsula of Michigan, where he worked as a miner and gravedigger to pay his way through college. He has a B.S. in Sociology and a M.A. in Journalism. Nathan speaks French and knows enough Swahili to get out of a tight spot.
Nathan Seppa's Articles
Like an aging actor rediscovered after being typecast for years, the long-standing diabetes drug metformin is poised to reinvent itself. A wealth of studies suggests the drug has cancer-fighting properties, and clinical trials are now under way to prove it.
- NewsRare prion ailment starts in adulthood, attacking the gut before brain.
- News in BriefA bone marrow transplant rid one child of his blood cancer and also an immune reaction to peanuts.
- NewsThough infant immune systems raise risk of infection, they also allow good microbes into the body, study in mice shows.
- NewsRegular exercise might limit broken bones due to bad falls in elderly people.
- News in BriefProteins suppress disease in monkeys, but don’t cure it.
- News in BriefHypertrophic pyloric stenosis, which causes forceful vomiting, is more common in babies not breast-fed.
- NewsMost monkeys given dual therapy survive infection with lethal virus.
- News in BriefMice exposed to loud sound before getting chemotherapy preserve valuable cells in the inner ear, a new study shows.
- Reviews & PreviewsSendhil Mullainathan and Eldar Shafir explain why having too little means so much.